Loading, please wait....jpg)
.jpg)
The Premier February 25, 2025 CE webinar will be held from 12 - 1 pm EST. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
Clean Data and Polished Compliance: Leveraging AI Diversion Software to Optimize Alerts and Improve Controlled Substance Processes
SPEAKER: Bethanie Gamble, PharmD, Diversion Coordinator- Upstate, Prisma Health Greenville Memorial Hospital, Greenville, SC
ACPE Universal Activity Number: 0122-0000-25-004-L04-P/T [0.1 CEU] [1 Contact Hr.]
Date: Feb 25, 2025 12:00 PM - 01:00 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Feb 25, 2025 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
CE participation will be provided to CPE Monitor within 45 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.
Support/Credits
Premier, Inc. has received no outside support for the administration of this program.
Registration closes on Feb 25, 2025
at 12:10 PM
Registration closes on Feb 25, 2025
at 12:10 PM
Registration Closed
Registration Closed
Objectives
- Identify specific data streams and unique workflows that should be captured within your organization’s artificial intelligence (AI) diversion software
- Outline diversion data cleaning techniques within a software solution and recognize the value these methods provide in mitigating the risk of identifying false positive risky team members
- Recognize specific categories involved in controlled substance handling that can increase ‘noise’ within AI diversion software
- Discuss ways to address those concerns with the goal of differentiating between compliance issues or diversion activity
- Describe how leveraging data to identify cultural issues of non-compliance can be utilized to drive unique process change and create key performance indicators (KPI)
- Discuss how to lead a drug diversion response team into more escalated steps when perceived risk cannot be explained
Speaker(s)/Author(s)
|
Bethanie Gamble, PharmD
|
Activity Number
0122-0000-25-004-L04-P/T
Date:
02/25/25
Time:
12:00 PM - 01:00 PM
CE Hours
1.00
Registration Closed